Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients
NCT00274001
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
158
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Quality of Life
Interventions
DRUG:
Nevirapine
Sponsor
Boehringer Ingelheim